Correlation Between Pharvaris and T2 Biosystms

Can any of the company-specific risk be diversified away by investing in both Pharvaris and T2 Biosystms at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pharvaris and T2 Biosystms into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Pharvaris BV and T2 Biosystms, you can compare the effects of market volatilities on Pharvaris and T2 Biosystms and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pharvaris with a short position of T2 Biosystms. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pharvaris and T2 Biosystms.

Diversification Opportunities for Pharvaris and T2 Biosystms

0.66

Correlation Coefficient

Pharvaris  T2 Biosystms

Poor diversification

The 3 months correlation between Pharvaris and TTOO is 0.66. Overlapping area represents the amount of risk that can be diversified away by holding Pharvaris BV and T2 Biosystms in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on T2 Biosystms and Pharvaris is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pharvaris BV are associated (or correlated) with T2 Biosystms. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of T2 Biosystms has no effect on the direction of Pharvaris i.e., Pharvaris and T2 Biosystms go up and down completely randomly.

Pair Corralation between Pharvaris and T2 Biosystms

Given the investment horizon of 90 days Pharvaris BV is expected to under-perform the T2 Biosystms. But the stock apears to be less risky and, when comparing its historical volatility, Pharvaris BV is 6.6 times less risky than T2 Biosystms. The stock trades about -0.15 of its potential returns per unit of risk. The T2 Biosystms is currently generating about -0.02 of returns per unit of risk over similar time horizon. If you would invest  57.00  in T2 Biosystms on November 28, 2024 and sell it today you would lose (39.00) from holding T2 Biosystms or give up 68.42% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	98.28%
Values	Daily Returns

Pharvaris BV  vs.  T2 Biosystms

Pharvaris BV

Risk-Adjusted Performance

Very Weak

Over the last 90 days Pharvaris BV has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in March 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

T2 Biosystms

Risk-Adjusted Performance

Very Weak

Over the last 90 days T2 Biosystms has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in March 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Pair Trading with Pharvaris and T2 Biosystms

The main advantage of trading using opposite Pharvaris and T2 Biosystms positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pharvaris position performs unexpectedly, T2 Biosystms can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in T2 Biosystms will offset losses from the drop in T2 Biosystms' long position.

The idea behind Pharvaris BV and T2 Biosystms pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.